Metrics as of 10/13/2026, 01:19 PM (Berlin time), refresh in progress.
SI-BONE Stock
SI-BONE, Inc.
Company data
- Sector
- Healthcare
- Industry
- Medical - Devices
- Country
- United States
- CEO
- Laura A. Francis
- Employees
- 376
- Market cap
- $873 M
- IPO
- 17/10/2018
- Web
- si-bone.com
SI-BONE, Inc. is a medical technology company that develops and markets specialized implantable solutions for musculoskeletal conditions affecting the sacropelvic region. These devices are utilized across the United States and internationally. Its flagship product, iFuse, is a minimally invasive surgical implant…
SI-BONE stock: price history
1D
-2.1%
1W
+0.7%
1M
+7.1%
6M
+36.4%
YTD
-0.2%
1Y
+31.7%
2Y
+49.9%
5Y
-9.0%
10Y
–
Next earnings date
Next earnings date
09/11/2026 (in 23 days)
Volatility around earnings
~80% stronger price swings than usual
Ask the agents about SI-BONE
Analyst assessment of SI-BONE
PRICE TARGET LOW
US$21.00
CONSENSUS
US$23.00
MEDIAN
US$23.00
PRICE TARGET HIGH
US$25.00
0
STRONG BUY
10
BUY
0
HOLD
0
SELL
0
STRONG SELL
10
TOTAL · Buy
As of: 04/08/2026
SI-BONE stock metrics
P/E
-57.92
P/B
4.77
EV/EBITDA
-169.43
RETURN ON EQUITY
-2.2%
NET MARGIN
-7.3%
DEBT/EQUITY
0.04
DIVIDEND YIELD
0.0%
AS OF
30/06/2026
Free float & liquidity
FREE FLOAT
97.5%
FLOAT SHARES
43,231,101
AVG. DAILY VOLUME (30D)
580,892
Insider transactions (SEC)
FRANCIS LAURA
Maheshwari Anshul
PISETSKY MICHAEL A.
Maheshwari Anshul
PISETSKY MICHAEL A.
Institutional holders
Comparable stocks
Frequently asked questions about SI-BONE stock
What does SI-BONE do?
SI-BONE, Inc. is a company in the Healthcare sector, Medical - Devices industry, headquartered in United States.
The CEO is Laura A. Francis, the company employs around 376 people.
The IPO was on 17/10/2018; the stock trades on NASDAQ under the ticker SIBN.
What do analysts say about SI-BONE stock?
10 analysts rate the stock, the consensus is Buy (as of 04/08/2026).
The average price target is US$23.00, ranging from US$21.00 to US$25.00, with a median of US$23.00.
This is an external assessment, not a statement by Market Jury.
When does SI-BONE report next?
The next earnings date is 09/11/2026.
Around past earnings, price swings were roughly 80% stronger than usual.
Does SI-BONE pay a dividend?
No, SI-BONE currently does not pay a dividend.
Which stocks are comparable to SI-BONE?
Comparable stocks include Abbott Laboratories, Stryker, Boston Scientific, Edwards Lifesciences, DexCom, GE HealthCare Technologies, Zimmer Biomet Holdings and Align Technology.
How can I get SI-BONE stock analyzed?
Clicking "Analyze stock" lets five strategies assess SI-BONE against fixed, published rules and judge it bullish, neutral or bearish. The jury states where it disagrees. A free account starts with 5 credits, a quick check costs 1 credit, a full analysis 2 credits.
Not investment advice. Past performance is not an indicator of future results.